Literature DB >> 14970096

Antidepressants and adverse effects in young patients: uncovering the evidence.

Andrew Herxheimer1, Barbara Mintzes.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Mental Health Therapies

Mesh：

Substances：

Year:  2004        PMID： 14970096      PMCID： PMC332715     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.

Authors:  Andreas Laupacis; J Michael Paterson; Muhammad Mamdani; Alaa Rostom; Geoffrey M Anderson
Journal:  CMAJ       Date:  2003-11-25       Impact factor: 8.262

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Facing the evidence: antidepressant treatment in children and adolescents.

Authors:  E Jane Garland
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

Review 4.  Secrecy and the health protection branch.

Authors:  J Lexchin
Journal:  CMAJ       Date:  1998-09-08       Impact factor: 8.262

5.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.

Authors:  J P Ioannidis; J Lau
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

6.  Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment.

Authors:  R A King; M A Riddle; P B Chappell; M T Hardin; G M Anderson; P Lombroso; L Scahill
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1991-03       Impact factor: 8.829

7.  Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

Authors:  Mark Zimmerman; Jill I Mattia; Michael A Posternak
Journal:  Am J Psychiatry       Date:  2002-03       Impact factor: 18.112
  7 in total
  15 in total

1.  SSRI treatment for under-18s.

Authors:  Mark A Voysey
Journal:  CMAJ       Date:  2004-06-08       Impact factor: 8.262

Review 2.  Efficacy and safety of antidepressants for children and adolescents.

Authors:  Jon N Jureidini; Christopher J Doecke; Peter R Mansfield; Michelle M Haby; David B Menkes; Anne L Tonkin
Journal:  BMJ       Date:  2004-04-10

Review 3.  Sikh birth customs.

Authors:  R Gatrad; J Jhutti-Johal; P S Gill; A Sheikh
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

Review 4.  Should paediatricians support the European Paediatric Clinical Trials Register?

Authors:  H M Sammons; C Naylor; I Choonara; C Pandolfini; M Bonati
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

5.  Manufacturing consensus.

Authors:  David Healy
Journal:  Cult Med Psychiatry       Date:  2006-06

6.  SSRIs and SNRIs: A review of the Discontinuation Syndrome in Children and Adolescents.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-02

Review 7.  Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

Authors:  A Blenkinsopp; P Wilkie; M Wang; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

8.  Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.

Authors:  Lise Aagaard; Lars Hougaard Nielsen; Ebba Holme Hansen
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Unlocking Health Canada's cache of trade secrets: mandatory disclosure of clinical trial results.

Authors:  Matthew Herder
Journal:  CMAJ       Date:  2011-08-29       Impact factor: 8.262

Review 10.  Reporting bias in medical research - a narrative review.

Authors:  Natalie McGauran; Beate Wieseler; Julia Kreis; Yvonne-Beatrice Schüler; Heike Kölsch; Thomas Kaiser
Journal:  Trials       Date:  2010-04-13       Impact factor: 2.279
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.